Merck & Co. Out-Licenses Gene Therapy Portfolio to Finnish Start-Up FKD Therapies
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 10 (Table of Contents)
Published: 3 Oct-2011
DOI: 10.3833/pdr.v2011.i10.1564 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Finnish start-up FKD Therapies, which was co-founded by the ex-CEO of Ark Therapeutics, has obtained an exclusive licence to develop and commercialise Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS